Home
overview

- * CHRISTMAS SPECIAL AVAILABLE * - 

Register by 15th December to save £500!

The SMi Group are thrilled to present the launch of Injectable Drug Delivery Conference 2018! The event is taking place in central London on 16th and 17th May 2018, with two pre-conference workshops occurring on 15th May 2018.

The Global Injectable Drug Delivery Market is expected to reach $789.7 billion USD by 2024, with a compound annual growth rate (CAGR) of 11.5% during the period of 2017 to 2024, according to Research Markets Reports. Therefore, this conference will aim to discuss the key developments in this field and the latest technological advancements.

Topics that will be covered include:

- Wearable, smart, connected and disposable devices
- Self-injection, auto-injection and a human-centric approach
- Next-generation drug delivery formulations
- Restricting drug uptake into healthy organs
- Global regulatory frameworks

We Are One of A Kind...

Networking: We keep networking at the forefront when it comes to our attendees. Expand your community with every part of the industry and with the right people to benefit your company and develop your career.

The Agenda: Be sure to have your pen and pad ready at all times! A valuable time is spent to discover the latest trends and hottest topics in the industry to provide the best possible agenda for our attendees.

Location/Venue: Being held in the heart of London, The Holiday Inn Kensington Forum, London is an elegant contemporary four-star hotel in prestigious Kensington, located just a few minutes’ walk from High Street Kensington underground station, making exploring easy. See the wonderful sights of Kensington, by visiting Kensington Palace, the historical Museums, or take a stroll in Kyoto Garden!

Onsite: Our knowledgeable events team will provide you with an exceptional service onsite. They will answer any questions you may have and inform you about any changes to the agenda.

The Conference:

  • Review device designs for a future portfolio
  • Explore risk management options for combination products
  • Hear how companies are tackling compatibility challenges of biologics with high volume injectors
  • Learn how vial-based novel delivery technologies can overcome complex dosing regiments
  • Discover how nanosystems can help address present and future challenges in injectable peptide delivery

Alkermes Plc., Antares Pharma, Battelle, Baxter International, Becton, Bend Research, BioDelivery Sciences, Bristol-Myers Squibb, Dickinson and Company, Elcam Medical, Eli Lilly and Company, Enesi Pharma, F. Hoffmann-La Roche Ltd, Flextronics Medical, Formac Pharmaceuticals, Genetech Inc, Gerresheimer AG, GlaxoSmithKline, Haselmeier, Mati Therapeutics, Merck & Co Inc, Mylan N.V., Nova Laboratories Ltd, Novartis, Novo Nordisk, Oncolytics Biotech, Owen Mumford Ltd, Parenteral Drug Association, Pfizer, PolyActivaUnilife, Roche, Rovi Contract Manufacturing S.L., Salvus Technology Limited, Sandoz, Sanofi, Schott AG, Terumo Corporation, Teva Pharmaceuticals Industries Ltd., Toxikon, West Pharmaceutical Services Inc, Xellia Pharmaceuticals, Ypsomed Holding AG..

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Jean Rene Authelin

Jean Rene Authelin, Global Head of Pharmaceutical Engineering, Sanofi-Aventis

Subject to final confirmation:

9:10 Injectable Drug Delivery: The Latest Regulations

Elizabeth Baker

Elizabeth Baker, Principal Pharmaceutical Officer Medical Drug Devi, MHRA

• Learn the latest regulations and how you can remain compliant
• A discussion of how best to interpret these regulations
• How to remain compliant with new regulations during clinical trials

Speaker to be confirmed: 

9:50 Interpreting the latest regulations: A pharmaceutical perspective

John Schalago

John Schalago, Regulatory Affairs Professional, Shire U S Inc

• Understand the impact latest regulations have on your products on the market and in clinical trhials
• See how Shire are remaining compliant
• Discussing challenges in remaining compliant and how to overcome these

Speaker subject to confirmation:

10:30 Designing devices for a future portfolio

Andrew Fiorini

Andrew Fiorini, Investigator, Device Engineering, GSK
View Bio

• Defining parameters and requirements
• Engaging stakeholders. How? Who? and when?
• Designing with the end users

11:10 Morning Coffee

11:40 What does it take to be patient centric?

Fie Falck Larsen

Fie Falck Larsen, Device Design Engineer, LEO Pharma A/S
View Bio

• Shaping usability to fit the organization
• Systemising user involvement with tools and templates
• Hands on experience with study design and implementation
• Involving key stakeholders in the process to secure anchoring of study insights

12:20 Vial Based Novel Delivery Technology

Maxime Gaillot

Maxime Gaillot, Senior Device Engineer, F. Hoffmann-La Roche Ltd
View Bio

• Weight based-dosing limits the primary packaging selection and impacts the number of potential different product presentations
• Discover how vial-based presentation can provide a solution to these complex dosing regiments
• Understand the background of vial-based presentation
• Learn the specifics of this novel delivery technology

13:00 How connected are we to our users

Uri Baruch

Uri Baruch, Head, Cambridge Design Partnership
View Bio

• There is a consensus these days that better usability will lead to better adherence and uptake
• One of the challenges we face today is how to get early real usability data to give us design insights to improve devices
• A novel approach is to use existing connected technology to monitor users over a longer time period than a formative study and understand long-term use behaviour such as training decay, adherence and use errors associated with longer use
• Jobs to be done approach is used to understand which metrics should be measured
• We will show Data analytics from long term studies we have conducted, discuss how there were analysed and what insights were gained

13:40 Networking Lunch

15:20 Should we combine products?

Margaret Kelly

Margaret Kelly, Device Development Project Leader, Novartis

• Discuss the benefits and disadvantages of combination products
• Know what is required from combination devices in the US
• Recognise the regulatory differences between the USD and Europe

Speaker subject to confirmation: 

15:40 Risk management for Medical Device and device part of combination product

Francseco Malavasi

Francseco Malavasi, Quality Risk Manager Medical Devices, Novartis Pharma GmbH
View Bio

• Risk management: Why and What
• Type of risk analysis
• Benefit during design control
• Case study of a PFS with NSD

16:00 Afternoon Tea

16:30 Will auto-injectors take over the market for primary drug containers?

Holger Roehl

Holger Roehl, Head of Primary Packaging Development, Roche Holding

• Reviewing the advantages of using the two different drug delivery pathways
• Discover the latest advancements in auto-injector devices
• Discussing the rising auto-injector market
• A presentation of clinical trials currently utilising auto-injectors

Speaker subject to confirmation:

17:10 Revolutionising the fill & finish processing

Mostafa Nakach

Mostafa Nakach, Head of Pharmaceutical Engineering Group, Sanofi-Aventis R&D

• Bullet points to be confirmed by the speaker

Speaker subject to final confirmation:

17:50 Chairman’s Closing Remarks and Close of Day One

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Joel Richard

Joel Richard, Senior Vice President, Peptides, IPSEN
View Bio

9:10 Injectable Peptide Delivery: How Can Nanosystems Help Address Present and Future Challenges

Joel Richard

Joel Richard, Senior Vice President, Peptides, IPSEN
View Bio

• Peptide therapeutic landscape
• Injectable peptide sustained-release (SR) formulations
• Peptide delivery to the brain
• Peptide delivery to tumors and cells
• Alternative non-invasive peptide delivery routes

9:50 Drug product: The big picture

Ahmed Youssef

Ahmed Youssef, Head of Parenteral Unit, GMP Manufacturing Group, Sanofi-Aventis
View Bio

• Formulation development
• Drug product The big picture
• From Lab to Industry

10:30 Morning Coffee

11:00 Compatibility challenges of biologics with high volume injectors

Pierre Goldbach

Pierre Goldbach, Late Stage Pharmaceutical and Processing Development, Roche Pharmaceuticals

• Delivery of high volume biologics subcutaneously
• Different types of devices for high volume injection
• Compatibility testing with high volume injectors
• Potential impact on biologics product quality

11:40 Wearable large volume injectors

Rene Holm

Rene Holm, Head & Scientific Director, Janssen

• Increasing patient compliance by making wearable devices
• How to best deal with viscus biological drugs
• Learn how to overcome challenges with wearable LVI devices

Speaker subject to confirmation:

12:20 Networking Lunch

13:50 PANEL DISCUSSION: Tackling high-volume and highly viscous drug formulations

Rene Holm

Rene Holm, Head & Scientific Director, Janssen

Joel Richard

Joel Richard, Senior Vice President, Peptides, IPSEN
View Bio

James Blakemore

James Blakemore, Senior Consultant, Cambridge Consultants Ltd

14:30 Tackling Insolubility

Jayne Lawrence

Jayne Lawrence, Professor, KCL

• Insolubility is a huge obstacle with injectable drugs
• Methods of dissolving water-insoluble active pharmaceutical ingredients (API’s) to improve drug solubility, including micelle, lipidic, crystalline solid and amorphous formulations.
• Case studies of improving the solubility of drugs

Speaker subject to final confirmation:

15:10 Afternoon Tea

15:10 Managing high-volume and highly viscus biologic drugs

Marco Gregorini

Marco Gregorini, Associate Director Biologics Development, Celgene Ltd

• Biologics are often difficult and painful to administer due to the high volume required and highly-viscus nature of the formula.
• The market for high-volume injection capabilities is estimated to grow to $7-10 billion USD in the next five years’.
• Minimising syringe diameter when using biologics

Speaker subject to final confirmation:

16:30 Restricting drug uptake into healthy organs

Andy Dundon

Andy Dundon, Director, Drug Delivery Group, GSK

• Improving the targeting of drugs
• Developing self-navigating drug formulas
• Other techniques to decrease toxicity to off-target organs

Speaker subject to confirmation:

17:10 Chairman’s Closing Remarks and Close of Day Two

+

FEATURED SPEAKERS

Ahmed Youssef

Ahmed Youssef

Head of Parenteral Unit, GMP Manufacturing Group, Sanofi-Aventis
Andrew Fiorini

Andrew Fiorini

Investigator, Device Engineering, GSK
Fie Falck Larsen

Fie Falck Larsen

Device Design Engineer, LEO Pharma A/S
Francseco Malavasi

Francseco Malavasi

Quality Risk Manager Medical Devices, Novartis Pharma GmbH
Joel Richard

Joel Richard

Senior Vice President, Peptides, IPSEN
Maxime Gaillot

Maxime Gaillot

Senior Device Engineer, F. Hoffmann-La Roche Ltd
Uri Baruch

Uri Baruch

Head, Cambridge Design Partnership

Ahmed Youssef

Head of Parenteral Unit, GMP Manufacturing Group, Sanofi-Aventis
Ahmed Youssef

He studied Pharmacy at the university of Tanta, Egypt where he also get his master degree in Pharmaceutical technology. He obtained his PhD in prediction of long term stability of protein formulations from the Ludwig Maximillian university in Munich Germany. He joined Sanofi in 2009 as a lab head for protein formulation development and since July 2015 he joined the GMP manufacturing group as head of parenteral unit for Clinical goods manufacturing. Ahmed has supervised the Drug product development of many projects in different phases mainly for Therapeutic proteins and antibodies. Starting from very early Phase formulation development going through formulation optimization, process development, 1ry packaging development and drug device combination ending with very late phase development, tech transfers and commercialization.

Andrew Fiorini

Investigator, Device Engineering, GSK
Andrew Fiorini

I have a B.Eng (Hons) in Mechanical Engineering from University of Malta and a MSc. in Biomedical Engineering from Imperial College London. I have been with GSK in Device Engineering for the past four years. I have worked on developing a number of different parenteral technologies, both in late stage commercialisation as well as early development. Currently I’m part of an Early stage parenterals team managing the development of device solutions for GSK future parenteral portfolio.
 

Chris Muenzer

Senior Device Technology Manager, Novartis
Chris Muenzer

Fie Falck Larsen

Device Design Engineer, LEO Pharma A/S
Fie Falck Larsen

Fie Falck Larsen is a senior usability engineer at LEO Pharma with more than 10 years’ experience within development of medical devices and combination products and has a passion for human factors engineering and patient centricity. She holds a master´s degree in design engineering from Aalborg University in Denmark. Fie joined LEO Pharma in 2015 and plays a central role in making usability come to life in the device organization. Today she is responsible for the injection device usability activities.

Fie Larsen

Device Design Engineer, LEO Pharma A/S
Fie Larsen

Francseco Malavasi

Quality Risk Manager Medical Devices, Novartis Pharma GmbH
Francseco Malavasi

Francesco brings along over 10 years of Medical Device industry experience and knowledge in several different business areas and a broad area of functions, including 4 years’ experience in “combination product” development. Currently is Medical Device Quality Risk manager at Novartis BTDM covering product and processes risk related activities for combination product (or borderline products) and medical Devices.
He has an aeronautical background nevertheless is currently is pursuing a degree as Management Engineering.

James Blakemore

Senior Consultant, Cambridge Consultants Ltd
James Blakemore

Joel Richard

Senior Vice President, Peptides, IPSEN
Joel Richard

Dr Joël Richard is presently leading all the Pharmaceutical Development activities of Peptides & Small Molecules for the Ipsen Company. Dr Richard has got his PhD in Materials Science/Colloids & Interface Science from University of Paris VI. He has more than 25 years of experience in chemistry and biopharmaceutical R&D, including several global senior leadership positions in various Biotech and Pharma companies, such as Ipsen, Merck Serono, Serono and Ethypharm.
Dr Richard has focused his research activity on new formulations and drug delivery systems (such as microspheres, nanoparticles,. . .), especially for injectable protein and peptide formulations. Dr Richard has published 68 peer-reviewed scientific papers, 8 book chapters and 2 editorials in various fields. He is the author of more than 120 international communications and 53 patent families.

Maxime Gaillot

Senior Device Engineer, F. Hoffmann-La Roche Ltd
Maxime Gaillot

Maxime Gaillot works for Roche since 2011. He has 15 years experience in the medical device and polymer industry. After some years, in the plastic closure industry, Maxime started his career in the Medical Device industry at Novartis. He worked on the development of a dual chamber pen injector and an electronic reusable injector. Since 2011 at Roche, he was a single mater expert for Needle Safety Device and supported the filing for a Rheumatoid Arthritis treatment and the development of the Roche Needle Safety Training Device. Currently, he is the Device Team Leader for several molecules and the ad interim Section Head for Device Engineering. In addition, Maxime is leading the development of a new vial based pen device to support clinical trial or challenges for weight based treatment. Maxime is graduated from the ENSAM Paris in Mechanical Engineering.

Pierre Goldbach

Late Stage Pharmaceutical and Processing Development, Roche Pharmaceuticals
Pierre Goldbach

Uri Baruch

Head, Cambridge Design Partnership
Uri Baruch

Uri heads up the drug delivery team at Cambridge Design Partnership, where he has led a variety of design projects including an award-winning needle safety device, an emergency auto-injector, pen injectors, and packaging design for delivery devices and inhalation products. These projects included compiling design history files and led to successful submissions to both the Food and Drug Administration and the European Medicines Agency in several submission categories.
Uri has a master’s degree in engineering from the IIT, where he specialised in MEMS design and materials engineering. He has worked in a variety of industries including aerospace and defence, medical devices, automotive and inkjet. He has extensive knowledge of design for manufacturing and process design.
 

Official Media Partner

Supporters

Workshops

Wearable Injectors : Serving Clinical and Healthcare System Needs
Workshop

Wearable Injectors : Serving Clinical and Healthcare System Needs

Holiday Inn Kensington Forum
15th May 2018
London, United Kingdom

VENUE

Holiday Inn Kensington Forum

97 Cromwell Road , London, United Kingdom

Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

HOTEL BOOKING FORM

Media Partners


ONdrugDelivery Magazine

Official Media Partner
http://ondrugdelivery.com

ONdrugDelivery Magazine is the highly regarded, world-leading series of sponsored themed drug delivery publications. Uniquely, each issue focuses tightly on one topic within the field of drug delivery. With a truly global readership already in excess of 40,000, and with contributions and loyal support from many of the most important companies in the drug delivery business - from among the largest to the smallest - ONdrugDelivery Magazine is a must for those in the industry who need to know what's going on in drug delivery.


Drug Development & Delivery

Official Media Partner
http://www.drug-dev.com

Drug Development & Delivery is a print/online content provider that presents the latest scientific methods in drug development for professionals.

Media Partners


GBI

Supporters
http://www.gbihealth.com/

GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.


Mednous

Supporters
http://www.MedNous.com

MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


Drug Target Review

Supporters
http://www.drugtargetreview.com

Drug Target Review’s quarterly magazine, website and annual events program provides high quality content with peer-written articles that are submitted exclusively by the world’s most respected scientists in their field. This attracts a committed base of readers, users and delegates made up of senior decision-makers from the life science and drug discovery industries at the top pharmaceutical companies, as well as academics and scientists from the top research institutes across the globe.


Technology Networks

Supporters
http://go.technologynetworks.com/subscribe-to-newsletters

Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


Drug Development Technology

Supporters
http://www.drugdevelopment-technology.com

Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


Inderscience Publishers

Supporters
http://www.inderscience.com

Inderscience is a dynamic, leading, independent journal publisher. The company disseminates the latest research across the broad fields of science, engineering and technology; management, public and business administration; environment, ecological economics and sustainable development; computing, ICT and internet/web services, and related areas. Inderscience offers over 35 years' experience in publishing and has succeeded in building a substantial collection approaching 400 high-quality peer-reviewed international research journals in both online and print formats. We offer a variety of ways to keep up-to-date with the latest published leading-edge research while our online collection represents a fully-searchable digital archive of around 60,000 articles.


Bentham Science

Supporters
http://www.benthamscience.com/

Bentham Science Publishers is a major STM journal publisher of 116 titles and 200 plus open access journals and print/online book series (Bentham eBooks). Bentham Science answers the information needs of the pharmaceutical and biomedical research community. Leading journals include Current Drug Metabolism (Impact Factor 5.113) and Current Medicinal Chemistry (Impact Factor 4.859): FREE online journals and information: www.benthamscience.com


Gate2Biotech

Supporters
http://www.gate2biotech.com

Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


Swiss Biotech Association

Supporters
http://www.swissbiotech.org/

The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.

SAVE TO


Outlook Calendar  OUTLOOK CALENDAR
Google Calendar  GOOGLE CALENDAR
ICal Calendar  ICAL CALENDAR
Yahoo! Calendar  YAHOO! CALENDAR

Holiday Inn Kensington Forum

97 Cromwell Road
London SW7 4DN
United Kingdom

Holiday Inn Kensington Forum

Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

HOTEL BOOKING FORM

Title

SubTitle
speaker image

Content


Title


Description

Download


WHAT IS CPD?

CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

CPD AND PROFESSIONAL INSTITUTES

There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

GLOBAL CPD

Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

Event Title

Headline

Text
Read More

I would like to speak at an event

I would like to attend an event

I would like to sponsor/exhibit at an event

SIGN UP OR LOGIN

Sign up
Forgotten Password?

Contact SMi GROUP LTD

UK Office
Opening Hours: 9.00 - 17.30 (local time)
SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
Registered in England No: 3779287 VAT No: GB 976 2951 71




Forgotten Password

Please enter the email address you registered with. We will email you a new password.